Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: A Gynecologic Oncology Group (GOG) study - 18/08/11
Abstract |
Objective |
The purpose of this study was to determine the feasibility of laparoscopically staging patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum, and to evaluate related effects.
Study design |
Patients without evidence of metastatic disease had laparoscopic bilateral para-aortic and pelvic lymph node dissection. Other procedures were individualized based on extent of the primary surgery; laparotomy was undertaken for identified resectable disease.
Results |
Ninety-five eligible patients were entered on 2 Gynecologic Oncology Group (GOG) protocols. Eleven were excluded. Fifty-eight patients (69%) underwent complete endoscopic staging with photographic documentation. Nine others (10%) were incompletely staged. Seventeen patients (20%) had laparotomy. In patients undergoing laparoscopy, 6% had bowel complications; 11% were found to have more advanced disease. Hospital stay was significantly shorter with laparoscopy alone (3 vs 6 days, P = .04).
Conclusion |
Interval laparoscopic staging of gynecologic malignancies can be successfully undertaken in selected patients, but laparotomy for adhesions or metastatic disease and risk of visceral injury may be anticipated.
Le texte complet de cet article est disponible en PDF.Key words : Laparoscopy, Interval staging, Gynecologic malignancy
Plan
| Supported by National Cancer Institute grants to the Gynecologic Oncology Group (GOG) Administrative Office (CA 27469), and the GOG Statistical and Data Center (CA 37517). The following GOG institutions participated in this study: Rush-Presbyterian-St Luke's Medical Center, Women's Cancer Center, Walter Reed Army Medical Center, University of Minnesota Medical School, University of Mississippi Medical Center, and University of Oklahoma. Reprint requests: Ms Denise Mackey, Gynecologic Oncology Group, 1600 John F. Kennedy Blvd, Suite 1020, Philadelphia, PA 19103. E-mail: dmackey@gog.org |
Vol 193 - N° 5
P. 1645-1649 - novembre 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
